Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2013||Chairman of the Board, President, Chief Executive Officer|
|51||2017||Chief Financial Officer, Executive Vice President|
|49||2016||Executive Vice President and Chief Strategy Officer|
|60||2015||Executive Vice President and Chief Medical Officer|
|44||2016||Executive Vice President and Chief Commercial Officer|
- BRIEF-Synergy Pharmaceuticals reports Q1 sales $100,000
- BRIEF-Synergy Pharmaceuticals says to present positive TRULANCE phase 3 data
- BRIEF-Synergy Pharmaceuticals appoints Gary Gemignani as chief financial officer
- BRIEF-Synergy Pharmaceuticals announces issuance of three new patents expected to extend Trulance patent protection until 2032
- BRIEF-Synergy Pharmaceuticals reports qtrly net loss per common share $0.31